Ironwood Pharmaceuticals Inc (IRWD) Unusual Options Activity Today

Checking IRWD unusual options activity helps you spot when traders are making outsized bets on Ironwood Pharmaceuticals Inc before the broader market catches on. Ironwood Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IRWD unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IRWD unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IRWD unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IRWD unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis.

The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Catalysts rarely arrive without a footprint, and IRWD unusual options activity is often where that footprint shows up first. Our scanner tracks Ironwood Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IRWD unusual options volume on the call side or chasing put sweeps, Ironwood Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.